Gabriel Ocana Santero holds an MSc in Neuroscience and PhD in Pharmacology from Oxford University, with research experience spanning gene therapy, pancreatic cancer, and muscle physiology at institutions in Boston, Vienna, and Stockholm. He has conducted work on neurodevelopment and serotonin signaling at the Gatsby Unit at UCL, and now develops gene therapies for neurological conditions at Exin Therapeutics.
Intro paths
YC
Gabriel went through Y Combinator (Winter 2025) — any YC alum in your network can reach them through the YC community.
→
In turn, Gabriel can intro founders to Exin Therapeutics's investors below.
Exin Therapeutics's investors · 1
Co-founders
Marko Tvrdic· Founder